Skip to main content
. 2022 Mar 7;14(5):1358. doi: 10.3390/cancers14051358

Table 1.

DVL Binding and WNT Pathway Inhibition by Compounds 1, (S)-1, (R)-1 and 2.

graphic file with name cancers-14-01358-i001.jpg graphic file with name cancers-14-01358-i002.jpg
1 2
EC50 ± SD (μM) a EC50 ± SD (μM) b
Compound DVL1 Binding Inhibition WNT Pathway Inhibition
1 0.74 ± 0.08 3.46 ± 0.07
(S)-1 0.49 ± 0.11 3.09 ± 0.05
(R)-1 29.5 ± 0.9 19.49 ± 0.06
2 5.10 ± 0.09 n.d.

a Inhibition of DVL1 binding. b Inhibition of the WNT pathway.